Cross-dressed CD8α+/CD103+ dendritic cells prime CD8+ T cells following vaccination

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 31, 2012, Pages 12716-12721

  Li, Jin ^a   Kim, Sojung ^a   Herndon, John M ^a   Goedegebuure, Peter ^a,b   Belt, Brian A ^a   Satpathy, Ansuman T ^a   Fleming, Timothy P ^a,b   Hansen, Ted H ^a,b   Murphy, Kenneth M ^a,b   Gillanders, William E ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Washington University in St Louis School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD103 ANTIGEN; CD8ALPHA ANTIGEN; DNA VACCINE; INTERLEUKIN 17; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TUMOR; VACCINATION; VIRUS INFECTION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD; ANTIGENS, CD8; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DENDRITIC CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; INTEGRIN ALPHA CHAINS; MICE; MICE, KNOCKOUT; PEPTIDES; VACCINATION;

EID: 84864517178     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1203468109     Document Type: Article

References (21)

1. Kurts C, Robinson BW, Knolle PA (2010) Cross-priming in health and disease. Nat Rev Immunol 10:403-414.
2. Dolan BP, Gibbs KD, Jr., Ostrand-Rosenberg S (2006) Dendritic cells cross-dressed with peptide MHC class I complexes prime CD8+ T cells. J Immunol 177:6018-6024. (Pubitemid 44628815)
3. Dolan BP, Gibbs KD, Jr., Ostrand-Rosenberg S (2006) Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines. J Immunol 176:1447-1455. (Pubitemid 43134287)
4. Wakim LM, Bevan MJ (2011) Cross-dressed dendritic cells drive memory CD8+ T-cell activation after viral infection. Nature 471:629-632.
5. Hildner K, et al. (2008) Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science 322:1097-1100.
6. Yu YY, Netuschil N, Lybarger L, Connolly JM, Hansen TH (2002) Cutting edge: Singlechain trimers of MHC class I molecules form stable structures that potently stimulate antigen-specific T cells and B cells. J Immunol 168:3145-3149. (Pubitemid 34250372)
7. Li L, et al. (2010) Engineering superior DNA vaccines: MHC class I single chain trimers bypass antigen processing and enhance the immune response to low affinity antigens. Vaccine 28:1911-1918.
8. Mitaksov V, et al. (2007) Structural engineering of pMHC reagents for T cell vaccines and diagnostics. Chem Biol 14:909-922. (Pubitemid 47268780)
9. Truscott SM, et al. (2007) Disulfide bond engineering to trap peptides in the MHC class I binding groove. J Immunol 178:6280-6289. (Pubitemid 46717411)
10. Kim S, et al. (2005) Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436:709-713. (Pubitemid 41117274)
11. Choudhuri K, Wiseman D, Brown MH, Gould K, van der Merwe PA (2005) T-cell receptor triggering is critically dependent on the dimensions of its peptide-MHC ligand. Nature 436:578-582. (Pubitemid 41112933)
12. Wang B, et al. (2009) A single peptide-MHC complex positively selects a diverse and specific CD8 T cell repertoire. Science 326:871-874.
13. Kim S, et al. (2010) Single-chain HLA-A2 MHC trimers that incorporate an immundominant peptide elicit protective T cell immunity against lethal West Nile virus infection. J Immunol 184:4423-4430.
14. Connolly JM, Hansen TH, Ingold AL, Potter TA (1990) Recognition by CD8 on cytotoxic T lymphocytes is ablated by several substitutions in the class I alpha 3 domain: CD8 and the T-cell receptor recognize the same class I molecule. Proc Natl Acad Sci USA 87:2137-2141.
15. Pascolo S, et al. (1997) HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice. J Exp Med 185:2043-2051. (Pubitemid 27265987)
16. Howarth M, Williams A, Tolstrup AB, Elliott T (2004) Tapasin enhances MHC class I peptide presentation according to peptide half-life. Proc Natl Acad Sci USA 101:11737-11742. (Pubitemid 39095365)
17. Vassar R, Rosenberg M, Ross S, Tyner A, Fuchs E (1989) Tissue-specific and differentiation-specific expression of a human K14 keratin gene in transgenic mice. Proc Natl Acad Sci USA 86:1563-1567. (Pubitemid 19078943)
18. Smyth LA, et al. (2008) The relative efficiency of acquisition of MHC:peptide complexes and cross-presentation depends on dendritic cell type. J Immunol 181:3212-3220.
19. Bevan MJ (1976) Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J Exp Med 143:1283-1288.
20. Hansen T, Yu YY, Fremont DH (2009) Preparation of stable single-chain trimers engineered with peptide, β2 microglobulin, and MHC heavy chain. Curr Protoc Immunol 2009;Chapter 17:Unit17.5.
21. Lybarger L, Wang X, Harris MR, Virgin, HW, 4th, Hansen TH (2003) Virus subversion of the MHC class I peptide-loading complex. Immunity 18:121-130. (Pubitemid 36120693)